Talviraline, CAS 163451-80-7

Product Description: Talviraline is a non-nucleoside reverse transcriptase (NNRT) inhibitor that is primarily used to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). Talviraline inhibits the viral replication process by binding to a specific site of HIV-1 reverse transcriptase (RT). Talviraline can be used to study the potential countermeasures and safety of HIV-1 infection[1].

Applications: COVID-19-anti-virus

Formula: C15H20N2O3S2

References: [1]Kleim J P, et al. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication[J]. Antimicrobial agents and chemotherapy, 1995, 39(10): 2253-2257.

CAS Number: 163451-80-7

Molecular Weight: 340.46

Research Area: Infection

Solubility: 10 mM in DMSO

Target: HIV;Reverse Transcriptase

• SKU: MEXHY-106958-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-106958-1
• Package Unit: 1 mg
• Quantity Unit: STK